Acelrx Pharmaceuticals reported $7.14M in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acelrx Pharmaceuticals ACRX:US USD 7.14M 7M
Baxter International BAX:US USD 3.7B 2.88B
Becton, Dickinson and BDX:US USD 4B 293M
Cara Therapeutics CARA:US USD 34.57M 90K
Heron Therapeutics HRTX:US USD 68.44M 8.69M
Intra Cellular Therapies ITCI:US USD 135.28M 7.78M
Johnson & Johnson JNJ:US USD 19.51B 1.54B
Pain Therapeutics PTIE:US USD 20.94M 408K
Pfizer PFE:US USD 19.12B 5.9B
Smiths SMIN:LN GBP 1.41B 379M
Teva Pharmaceutical TEVA:IT USD 4.74B 1.56B
Xeris Pharmaceuticals Inc XERS:US USD 48.31M 191K